 The common stock has been approved to list on the Nasdaq Capital Market under the symbol DUOT and is expected to begin trading on February 13, 2020. The Company intends to use the net proceeds from this offering to research and development activities, sales and marketing, and for general working capital purposes. The Company has also granted the underwriters a 45-day option to purchase up to an additional 202,500 shares of common stock. 